The Efficacy of Auto-cross Linked Hyaluronic Acid Gel in the Prevention of Adhesion Reformation After Hysteroscopic Resection of Retained Products of Conception

Recruiting N/A Interventional Study
Retained Products of Conception
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 45
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
86 (estimated)
Sponsor
Fu Xing Hospital, Capital Medical University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Retained product of conception (RPOC) is defined by abnormal trophoblastic persistence or retained placenta inside the uterus cavity after a pregnancy independently of the outcome. Untreated RPOC can compromise future fertility. RPOC are generally treated surgically, either by repeated evacuation or by hysteroscopy, which exposes the uterus to additional potential trauma.The combination of trauma …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of retained products of conception * Written consent obtained Exclusion Criteria: * Patients with severe complications of medicine and surgery * Acute or chronic genital tract inflammation * No understanding or approving the randomized controlled trial
Contacts

Xue Yang, Master

8618810957056

yuanxy515@163.com

CONTACT

Rong Li Huo, Doctor

8601088062032

fxyykjc2014@sina.com

CONTACT